LePure, a China-based bioprocess equipment developer, raised a ~CNY100m (~USD15m) Series C led by General Atlantic, Novo Holdings and Goldman Sachs Asset Management, with follow-on from Highlight Capital, Bayland Capital, HM Capital, CSTC and Huaying Health Fund. Read more